Marina Chiara Garassino to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Marina Chiara Garassino has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.080
-
Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC Study. J Thorac Oncol. 2019 08; 14(8):1390-1399.
Score: 0.041
-
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial. Clin Lung Cancer. 2019 05; 20(3):e413-e417.
Score: 0.039